05/15/2025
2:14 PM | ARMISTICE CAPITAL, LLC (Filed by)
Calidi Biotherapeutics (Subject)
| Form SCHEDULE 13G | |
05/14/2025
3:45 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2025
3:30 PM | Calidi Biotherapeutics (Filer)
| Form PRE 14A | |
05/02/2025
3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
5:01 AM | Calidi Biotherapeutics (Issuer)
Poma Eric E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/25/2025
5:05 AM | Calidi Biotherapeutics (Issuer)
Poma Eric E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
7:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
8:57 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
5:07 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
3:52 PM | Calidi Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
5:00 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for CLDI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Calidi Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/10/2025
4:21 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
4:28 PM | Calidi Biotherapeutics (Filer)
| Form 8-K/A | |
02/09/2025
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
02/05/2025
5:27 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/28/2025
7:30 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:58 PM | Calidi Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/10/2025
3:24 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
7:30 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/10/2025
7:30 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
3:01 PM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/03/2025
4:25 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:27 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2024
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
12/18/2024
8:29 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
5:13 AM | Calidi Biotherapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/29/2024
4:00 PM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/18/2024
7:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:02 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
5:03 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/14/2024
5:21 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/12/2024
4:08 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
9:05 AM | Calidi Biotherapeutics (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
10/24/2024
4:18 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
8:38 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/23/2024
7:25 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/18/2024
4:25 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
4:29 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Silver Is the New Oil—And the World’s Running Dry (Ad) Elon's Next Market Move Could Send Silver Soaring
Every industry Elon Musk touches explodes—from Tesla to SpaceX to AI.
And now, whispers are growing that his next move could be in silver.
Why? Because silver is the lifeblood of EVs, solar panels, and AI tech. Smart money is already watching silver closely. |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
4:05 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
09/30/2024
5:53 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
8:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
5:10 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:12 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
3:04 PM | Calidi Biotherapeutics (Subject)
Funicular Funds, LP (Filed by)
| Form SC 13G | |
08/22/2024
4:16 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
5:04 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
4:10 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
8:15 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
3:58 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
3:51 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2024
3:53 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
7:20 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:22 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:12 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:14 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:16 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:18 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:15 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Jackson Andrew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Campbell Wendy Pizarro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Minev Boris Radoslavov (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:15 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
4:24 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
